Abstract
To investigate the detailed molecular mechanism of mammary carcinogenesis and discover novel therapeutic targets, we previously analysed gene expression profiles of breast cancers. We here report characterization of a significant role of DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein) in mammary carcinogenesis. Semiquantitative RT–PCR and northern blot analyses confirmed upregulation of DTL/RAMP in the majority of breast cancer cases and all of breast cancer cell lines examined. Immunocytochemical and western blot analyses using anti-DTL/RAMP polyclonal antibody revealed cell-cycle-dependent localization of endogenous DTL/RAMP protein in breast cancer cells; nuclear localization was observed in cells at interphase and the protein was concentrated at the contractile ring in cytokinesis process. The expression level of DTL/RAMP protein became highest at G1/S phases, whereas its phosphorylation level was enhanced during mitotic phase. Treatment of breast cancer cells, T47D and HBC4, with small-interfering RNAs against DTL/RAMP effectively suppressed its expression and caused accumulation of G2/M cells, resulting in growth inhibition of cancer cells. We further demonstrate the in vitro phosphorylation of DTL/RAMP through an interaction with the mitotic kinase, Aurora kinase-B (AURKB). Interestingly, depletion of AURKB expression with siRNA in breast cancer cells reduced the phosphorylation of DTL/RAMP and decreased the stability of DTL/RAMP protein. These findings imply important roles of DTL/RAMP in growth of breast cancer cells and suggest that DTL/RAMP might be a promising molecular target for treatment of breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Adams RR, Carmena M, Earnshaw WC . (2001). Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 11: 49–54.
Bange J, Zwick E, Ullrich A . (2001). Molecular targets for breast cancer therapy and prevention. Nat Med 7: 548–552.
Banks D, Wu M, Higa LA, Gavrilova N, Quan J, Ye T et al. (2006). L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle 5: 1719–1729.
Carmena M, Earnshaw WC . (2003). The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4: 842–854.
Cheeseman IM, Anderson S, Jwa M, Green EM, Kang J, Yates III JR et al. (2002). Phospho-regulation of kinetochore-microtubule attachments by the Aurora kinase Ipl1p. Cell 111: 163–172.
Cheung WM, Chu AH, Chu PW, Ip NY . (2001). Cloning and expression of a novel nuclear matrix-associated protein that is regulated during the retinoic acid-induced neuronal differentiation. J Biol Chem 276: 17083–17091.
Dechat T, Gotzmann J, Stockinger A, Harris CA, Talle MA, Siekierka JJ et al. (1998). Detergent-salt resistance of LAP2alpha in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics. EMBO J 17: 4887–4902.
Goto H, Yasui Y, Kawajiri A, Nigg EA, Terada Y, Tatsuka M et al. (2003). Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process. J Biol Chem 278: 8526–8530.
Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H . (2006a). L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 5: 1675–1680.
Higa LA, Wu M, Ye T, Kobayashi R, Sun H, Zhang H . (2006b). CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol 8: 1277–1283.
Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T et al. (2006). Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol 29: 799–827.
Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T . (2007). Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of Bcl-2 family. Breast Cancer Res 9: R17.
Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N et al. (2005). Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene 24: 6201–6212.
Nagayama S, Iiizumi M, Katagiri T, Toguchida J, Nakamura Y . (2004). Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas. Oncogene 23: 5551–5557.
Navolanic PM, McCubrey JA . (2005). Pharmacological breast cancer therapy (review). Int J Oncol 27: 1341–1344.
Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F et al. (2004). Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol 25: 797–819.
Ohashi S, Sakashita G, Ban R, Nagasawa M, Matsuzaki H, Murata Y et al. (2006). Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies. Oncogene 25: 7691–7702.
Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T . (2006). PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen having an oncogenic activity in breast cancer. Cancer Res 66: 9186–9195.
Parkin DM, Bray F, Ferlay J, Pisani P . (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108.
Petricoin III EF, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K et al. (2002). Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 32 (Suppl): 474–479.
Sansam CL, Shepard JL, Lai K, Ianari A, Danielian PS, Amsterdam A et al. (2006). DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev 20: 3117–3129.
Severson AF, Hamill DR, Carter JC, Schumacher J, Bowerman B . (2000). The aurora-related kinase AIR-2 recruits ZEN-4/CeMKLP1 to the mitotic spindle at metaphase and is required for cytokinesis. Curr Biol 10: 1162–1171.
Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y, Katagiri T . (2007). Elevated expression of PRC1, protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci 98: 174–181.
Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, Lin YM et al. (2003). Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63: 6116–6120.
Terada Y . (2001). Role of chromosomal passenger complex in chromosome segregation and cytokinesis. Cell Struct Funct 26: 653–657.
Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y et al. (2005). Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 65: 4817–4826.
Acknowledgements
We thank Ms Kyoko Kijima for excellent technical assistances.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Ueki, T., Nishidate, T., Park, J. et al. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 27, 5672–5683 (2008). https://doi.org/10.1038/onc.2008.186
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.186
Keywords
This article is cited by
-
Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma
Genes & Genomics (2022)
-
DDB2 regulates DNA replication through PCNA-independent degradation of CDT2
Cell & Bioscience (2021)
-
Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis
Scientific Reports (2021)
-
Functional genomics for breast cancer drug target discovery
Journal of Human Genetics (2021)
-
DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
Journal of Experimental & Clinical Cancer Research (2019)